EMEQ ETF Analysis: Macquarie Focused Emerging | NASDAQ
Diversified Emerging Mkts | NASDAQ, USA | Market Cap: 601m USD | 12M Return: 94.9% | US5559275087 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.32M
Warnings
Tailwinds
Seasonality 1.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Macquarie Focused Emerging Markets Equity ETF (EMEQ) is a U.S.-listed exchange-traded fund that primarily invests in equity securities of companies headquartered or operating in emerging market countries. Under normal market conditions, the fund commits at least 80% of its net assets (including borrowings used for investment purposes) to these emerging markets equities, with no restrictions on company size, allowing exposure across large-, mid-, and small-cap firms.
As a non-diversified fund, EMEQ is permitted to hold more concentrated positions in a smaller number of issuers compared to diversified funds, which can result in higher volatility but also the potential for greater returns from successful stock selections. The fund provides investors with targeted access to growth opportunities in developing economies, where sectors such as consumer goods, technology, financials, and natural resources often play significant roles in market activity. Listed on NASDAQ and categorized within the Diversified Emerging Markets segment, EMEQ offers a focused approach to capturing equity performance across rapidly developing regions globally.
- AUM growth driven by retail investor inflows into EM exposure
- US dollar weakness lifts emerging market equity returns
- China and India stock performance drives top EM holdings
As of September 22, 2026, the stock is trading at USD 67.91 with a total of 99,504 shares traded. Over the past week, the price has changed by +7.06%, over one month by +3.25%, over three months by -13.05% and over the past year by +94.86%.
Current recommended Stop Loss: 64.80 (which is 4.6% or 2 ATR below the current price).
Macquarie Focused Emerging has no consensus analysts rating.